Company Announcements

Form 8.5 (EPT/NON-RI) - TAKEDA PHARMACEUTICAL

Source: RNS
RNS Number : 6276M
Morgan Stanley
09 January 2019
 

 

 FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley MUFG Securities Co., Ltd.

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical Company Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date position held/dealing undertaken

     For an opening position disclosure, state the latest practicable date prior to the disclosure

08 JANUARY 2019

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

Yes - Shire plc

 

 

 

2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

 (a)       Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 Class of relevant security:

Ordinary

 


 Interests

Short positions

 

 Number

  %

Number

  %

 (1) Relevant securities owned  and/or controlled:

4,423,915

0.56

35,544,949

4.53

 (2) Cash-settled derivatives:

34,686,223

4.42

3,545,959

0.45

 

 (3) Stock-settled derivatives (including options) and  agreements to purchase/sell:

315,000

0.04

315,000

0.04

  TOTAL:

39,425,138

5.03

39,405,908

5.02

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

 Class of relevant security in relation to which subscription right exists:

 N/A

 Details, including nature of the rights concerned and relevant percentages:

 N/A

 

 

3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

 

(a)        Purchases and sales

 

 Class of

relevant

security

 Purchases/

sales

 Total number

of securities

 Highest price

per unit paid/received

 Lowest price

per unit paid/received

 Ordinary

 PURCHASES

 3,061,136

 4,150.3600 JPY

 3,972.2495 JPY

 

 Ordinary

 SALES

 3,014,772

 4,150.3600 JPY

 3,972.2495 JPY

 

 

(b)        Cash-settled derivative transactions

 

  Class of

relevant

security

 Product description

 e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per

unit

Ordinary

CFD

SHORT

14500

4085.0000 JPY

Ordinary

CFD

LONG

27000

4064.2296 JPY

Ordinary

CFD

SHORT

68300

4096.2152 JPY

Ordinary

CFD

LONG

7000

4085.0000 JPY

Ordinary

CFD

SHORT

24900

3977.1927 JPY

Ordinary

CFD

LONG

32700

4067.0366 JPY

Ordinary

CFD

SHORT

6500

4046.0000 JPY

Ordinary

CFD

LONG

39200

4061.2015 JPY

Ordinary

CFD

SHORT

1800

4068.1666 JPY

Ordinary

CFD

SHORT

5400

4082.4074 JPY

Ordinary

CFD

LONG

3800

4068.4210 JPY

Ordinary

CFD

LONG

200

4043.0000 JPY

Ordinary

CFD

LONG

300

4068.1086 JPY

Ordinary

CFD

LONG

4300

4068.1086 JPY

Ordinary

CFD

SHORT

300

4056.0000 JPY

Ordinary

CFD

SHORT

9100

4057.8461 JPY

Ordinary

CFD

LONG

8400

4061.5357 JPY

Ordinary

CFD

SHORT

2400

4037.9166 JPY

Ordinary

CFD

LONG

1200

3995.0000 JPY

Ordinary

CFD

LONG

111196

4056.1075 JPY

Ordinary

CFD

SHORT

155697

4010.1029 JPY

Ordinary

CFD

LONG

65800

4064.7501 JPY

Ordinary

CFD

LONG

601408

4043.0780 JPY

Ordinary

CFD

SHORT

703308

4062.0253 JPY

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

 Class

of

relevant

security

 Product description  e.g. call option

 Writing, purchasing,

selling,

varying etc.

 Number

of securities to which option relates

 Exercise price

per unit

 Type

e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(ii)        Exercise

 

 Class of

relevant

security

 Product description

e.g. call option

 Exercising/

exercised

against

 Number of securities

 Exercise price

per unit

 

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(d)        Other dealings (including subscribing for new securities)

 

 Class of relevant

security

 Nature of dealing

e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A  

 

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 (b)       Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c)        Attachments

 

   Is a Supplemental Form 8 (Open Positions) attached?

                 YES  

 

 

 

 Date of disclosure:

 09 JANUARY 2019

 

 Contact name:

 Craig Horsley

 

 Telephone number:

 +44(141) 245 7736

 

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,

AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1.         KEY INFORMATION

 

Full name of person making disclosure:

Morgan Stanley MUFG Securities Co., Ltd.

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Takeda Pharmaceutical Company Limited

 

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities

to which

option or

derivative relates

Exercise

price

per unit

Type

e.g. American,

European

etc

Expiry

date

Ordinary

PUT

PURCHASED

125,000

4507.0000 JPY

European

13/12/2019

Ordinary

CALL

PURCHASED

125,000

4507.0000 JPY

European

13/12/2019

Ordinary

PUT

PURCHASED

60,000

4596.0000 JPY

European

14/06/2019

Ordinary

CALL

PURCHASED

60,000

4596.0000 JPY

European

14/06/2019

Ordinary

PUT

PURCHASED

65,000

4414.0000 JPY

European

14/06/2019

Ordinary

CALL

PURCHASED

65,000

4414.0000 JPY

European

14/06/2019

Ordinary

PUT

PURCHASED

65,000

4414.0000 JPY

European

13/12/2019

Ordinary

CALL

PURCHASED

65,000

4414.0000 JPY

European

13/12/2019

 

 

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEANFNELPNEEF